NCT02073968View on ClinicalTrials.gov

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

November 30, 2020

Conditions
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIB Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Interventions
DRUG

Carboplatin

Given IV

PROCEDURE

Computed Tomography

Undergo PET-adjusted IMRT

RADIATION

Intensity-Modulated Radiation Therapy

Undergo PET-adjusted IMRT

DRUG

Paclitaxel

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET-adjusted IMRT

RADIATION

Proton Beam Radiation Therapy

Undergo proton beam radiation therapy

Trial Locations (2)

10461

Albert Einstein College of Medicine, The Bronx

10467-2490

Montefiore Medical Center - Moses Campus, The Bronx

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT02073968 - PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter